Hepatitis B virus (HBV), although a DNA virus, replicates using reverse transcriptase encoded by the HBV polymerase (pol) gene. The biochemical dissection of HBV pol has been hampered by failure to liberate enzymatically active protein from nucleocapsids. Here, we have employed a yeast-based genetic approach to express the HBV reverse transcriptase. In this strategy, the reverse transcriptase of yeast retrotransposon Ty1 element is replaced with the HBV pol gene to produce the hybrid Ty1/HBV element. Additionally, the indicator gene his3AI is combined in an antisense orientation to the transcripts of the hybrid Ty1/HBVRT element. The splicing of his3AI, cDNA synthesis of the Ty1/HBVRT RNA and subsequent integration relies on the reverse transcriptase activity. The production of histidine prototrophs results from the successful reverse transcription of Ty1/HBVRThis3AI transcripts followed by either homologous recombination or integrase-mediated insertion and subsequent expression of HIS3 gene. Using this approach we successfully detected the reverse transcriptase activity of HBV in yeast strains defective in endogenous Ty1 expression. Consistent with the unique priming activity associated with HBV pol, the minus strand DNA synthesis was protein-primed. Deletion of HBV reverse transcriptase (RT) or RNase H domains resulted in a dramatic drop in histidine prototrophs. The addition of HBV encoded HBx protein in virus-like particles during in vitro RT reaction stimulated the RT reaction by severalfold. Furthermore, in the presence of 3TC, a known inhibitor of HBV reverse transcriptase, yeast His ؉ growth of His protrophs was not observed. Thus, this approach, which is based on genetic selection in yeast, is safe, economic, and a reliable strategy with a potential for large scale screening of cofactors and inhibitors of HBV polymerase functions.
Hepatitis B virus is one of the causative agents of acute/ chronic hepatitis in humans, which is a major health problem worldwide. It is estimated that over 500 million individuals are hepatitis B carriers worldwide and about 1 million deaths are attributed annually to the effects of HBV 1 infection (1). There is a strong correlation between chronic hepatitis B infection and the incidence of hepatocellular carcinoma. Immunization against HBV has been effective in reducing the number of new infections. Additionally interferon and nucleoside analog treatments have been employed for HBV-infected individuals with limited success. Approaches other than the vaccine have not been successful in eradicating the disease entirely. Therefore, there is an urgent need to develop alternative therapeutic methods and effective drug treatments to combat and or reduce the onset of chronic liver disease.
Human hepatitis B virus contains a small 3.2-kilobase DNA genome and is a member of the hepadnaviridae family, a group of viruses with a strong tropism for the liver (2) . Other members are found in woodchucks, ground squirrels, and several avian species. At least four proteins (surface protein, core protein, polymerase, and HBx) are translated from the mammalian HBV genome. HBV utilizes the strategy of replication via reverse transcription. The polymerase (pol) protein encoded by HBV consists of three domains: terminal protein (TP), pol/ reverse transcriptase (RT), and RNase H (RH). TP domain is separated from the other two domains by a spacer or tether sequence. The pol activity is utilized during HBV replication to convert a greater than genome-length RNA intermediate, known as pregenome RNA, into an asymmetric or partially duplex DNA that is maintained in a circular conformation. The details of HBV replication have emerged from the work of several laboratories (3) (4) (5) (6) . According to these reports, the first step of HBV replication appears to be the recognition of pregenomic RNA by polymerase at a stem loop structure termed ⑀ located within its own mRNA (7, 8) . Studies of in vitro translated (4) and yeast transposon-derived duck HBV-like virus pol (3) provided the first clues by revealing that a novel protein priming reaction initiates the minus strand DNA synthesis. This priming step yielded a discrete 3-4-deoxyribonucleotide oligomer that is covalently linked to the TP domain of HBV pol protein. The dNTPs are polymerized onto a tyrosine 63 acceptor residue located in the N-terminal priming TP domain. Priming is templated by a bulge within the ⑀ stem-loop structure located near the 5Ј end of the pregenomic RNA. The ⑀ motif and an additional 10 -11-nucleotide sequence termed DR are also found in the 3Ј end of the terminally redundant pregenome RNA. This redundancy facilitates the translocation of initiated DNA-protein complex to the 3Ј end of pregenomic RNA and ensures the continuation of minus strand synthesis. The pol covalently linked to initial minus strand DNA upon translocation to a complementary sequence in the 3Ј end of pregenome RNA resumes minus strand DNA synthesis. RNaseH activity of pol protein hydrolyzes the pregenome RNA following its reverse transcription. A ribonucleotide primer of 15 nucleotides including the CAP structure is recruited to initiate plus strand DNA synthesis at the DR2 sequence near the 3Ј end. The series * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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of reactions result into a DNA product that has a circular conformation. Core particles in which these reactions occur are either recycled through nucleus or enveloped with surface antigen to bud off as mature virion particles from cell surface (2) .
Reverse transcription has been observed in a wide variety of genetic elements including all retroviruses, transposons, bacteria, animals, and plants (9) . Yeast has several classes of endogenous retrotransposons (Ty) elements that transpose through RNA intermediate, and their replication is dependent upon Ty element-encoded reverse transcriptase (23) . Hybrid Ty and other retroelements have been used to demonstrate the RT activity of duck HBV-like virus (3), human long interspersed nuclear elements (10) , and long interspersed nuclear elementlike elements from trypanosomatids (11) . Although the retroviruses reverse transcription is understood in great detail, the biochemical dissection of HBV pol has been hampered by failure to obtain enzymatically active protein from nucleocapsids. In this report, we have employed a genetic selection scheme recently described for HIV RT that utilizes a Ty1 elementbased expression system in Saccharomyces cerevisiae (18, 19) . In the construct pTy1/HBVRT, the Ty1 RT (TyB) coding sequences were substituted with HBV pol open reading frame. For genetic selection HIS marker was added in the construct that exists in an antisense orientation. Reverse transcription yields a cDNA copy of the hybrid element carrying a functional HIS gene. The conversion of Ty1 RNA into DNA occurs within the virus-like particles known as VLPs. Upon transposition in yeast chromosome either by homologous recombination or via Ty1 integrase-mediated insertion, expression of HIS gene leads to histidine prototrophy. Thus, the expression of his marker in the present system totally relies on the HBV pol activity. Although our biochemical analyses and genetic selection support the functional activities of HBV pol, the system was also capable of detecting the failure of HBV RT activity in the presence of a nucleoside triphosphate 3TC on solid medium. Thus this approach suggests the feasibility of the system for large scale screening of inhibitors of HBV RT/RH activities. 3TC is a known inhibitor of HBV pol activities (12) .
MATERIALS AND METHODS
Yeast Strains-The yeast strain 1052 (Mat␣ ura-167 trp1-GB spt3-101 his⌬200 Rad52) was used to monitor reverse transcription of hybrid Ty1/HBVRT retroelement. The spt3 mutation blocks the expression of endogenous TY element. The His3-⌬200 mutation deletes the entire HIS3 gene. Rad52 mutation blocks the integration of plasmid borne Ty element into chromosome by homologous recombination. Plasmids-A 2.4-kilobase fragment flanked by the ClaI and SmaI restriction sites encompassing the entire HBV open reading frame including TP, RT, and RNase H domains was polymerase chain reaction-amplified from plasmid pNET. This fragment was cloned into the ClaI and SmaI sites of plasmid pHART to generate a hybrid construct Ty1/HBVRThis3AI (pTy1/HBVRT). Galactose-regulated Ty-his3AI plasmid pNuvec08 was used as a control (19) . Both pHART and pNuvec08 were kind gifts of Drs. Dwight Nissley, David Garfinkel, and Jeffrey Strathern of ABL of the National Cancer Institute (Frederick, MD). pHART contains the Ty1 protease, an integrase, and HIV reverse transcriptase (RT) domain (18, 19) . The plasmid Ty1/HBVRT was constructed by replacing the HIV RT sequences in the pHART plasmid. The junctions of Ty integrase with HBV pol open reading frame was confirmed by DNA sequencing. Two deletion mutants of HBV pol open reading frame were generated. pTy1/HB⌬RT contains a deletion of an 1.4-kilobase BamHI fragment that includes a major part of RT domain. The second deletion mutant pTy1/HBV⌬RH contains a 70-base pair NcoI-SstII deletion fragment encompassing the RNase H domain of the pol protein.
In Vivo Reverse Transcription Assay-Yeast cultures containing the appropriate constructs were grown in YMIN medium with 2% glucose, lacking uracil. Saturated yeast culture were then harvested and pellet washed in sterile water. Cells were grown for 1-2 h with 2% raffinose.
For induction of reverse transcription, 1 ml of yeast culture was then grown in YMIN medium with 2% galactose, 2% glycerol, and 2% ethanol at either 30 or 20°C for 12-16 h. After induction the yeast cells were diluted in water and simultaneously plated on plates with histidine for cell counts and without histidine for scoring His ϩ prototrophs. The ratio of His ϩ colonies/total number of yeast colonies is shown in Table I . Purification of VLPs-Ty virus-like particles were isolated by a modification of the method of Mathias et al. (11) . Yeast strain 1052 containing Ty-derived plasmids or their derivatives were grown in 2000 ml of YMIN synthetic medium with 2% glucose to an A 590 of 2. Cells were collected and diluted 2.5-fold in SC-ura medium (0.16% yeast nitrogen base and 0.5% ammonium sulfate) with 2% raffinose and grown for 2-3 h. Cultures were induced by the addition of 2% galactose, 2% glycerol, and 2% ethanol and grown for 16 -24 h. Cells were collected and suspended in 6 ml of B/EDTA buffer (15 mM KCl, 10 mM HEPES, pH 8.8, 5 mM EDTA, 3 mM 1,4-dithiothreitol, 2 mM phenylmethanesulfonyl fluoride, and 0.1 unit/ml aprotenin. Cells were lysed by vortex mixing with glass beads (12 gm) for 3-5 min. The lysates were clarified by centrifugation at 5,000 rpm in Sorvall SW34 rotor for 10 min. The supernatant was loaded onto a step gradient of 20%/30%/70% sucrose in B/EDTA (18 ml/6 ml/5 ml) and centrifuged for 3 h in SW28 rotor at 25,000 rpm. The fractions were collected from 30%/70% interphase and diluted in B/EDTA buffer and further centrifuged for 1 h at 45,000 rprm in SW55. The pellet was resuspended in B/EDTA containing 5% sucrose and stored at Ϫ70°C. For Western blotting yeast cells were lysed with 0.5% Nonidet P-40 and subjected to 8% SDS-PAGE. The gel was transferred onto nitrocellulose membrane and incubated with appropriate sera. The immunoreactive bands were visualized by a chemiluminiscence procedure (Amersham Pharmacia Biotech). Anti HBVpol was a generous gift of Dr. R. Lanford (Southwest Foundation for Biomedical Research, San Antonio, TX).
HBV Polymerase Assay in Vitro-VLPs extracts were partially purified as above, and 10 g of protein was incubated for 75 min at 24 C in 30 l containing [␣-
32 P]dCTP and 10 M dGTP, dATP, and dTTP each, in 60 mM Tris, pH 8.0, 12.5 mM MgCl 2 , and 2.5% v/v 2-mercaptoethanol. Where indicated VLPs were incubated with 10 units of micrococcal nuclease (Roche Molecular Biochemicals) in 7 mM CaCl 2 for 30 min to remove the endogenous DNA within VPLs prior to labeling reaction. Micrococcal nuclease activity was terminated by adding 15 mM EGTA. Actinomycin D (100 g; Roche Molecular Biochemicals) was added to the reaction mixture. Where indicated the labeled products of the polymerase reaction were treated with mung bean nuclease at 10 units/ reaction for 90 min at 37°C after completion of labeling. An HBV pol inhibitor lamivudine 3TC triphosphate was included in the RT reaction. The RT product was separated on 1.5% agarose gel containing 50 mM NaOH and 1 mM EDTA pH 8.0. The running buffer contained 50 mM NaOH and 1 mM EDTA pH 8.0. For the protein priming reaction, 10 g of protein was incubated with 1 Ci of [ 32 P]dGTP in the absence of RT buffer (60 mM Tris, pH 8.0, 12.5 mM MgCl 2 , and 2.5% v/v 2-mercaptoethanol and protease inhibitors).
RESULTS
Expression Strategy-In this study, we used yeast Ty1 retrotransposon-based chimeric construct to express the functional HBV pol protein. Ty1 retrotransposition is a replicative process involving reverse transcription of Ty1 mRNA and integration of Ty cDNA into the yeast genome. Yeast Ty1 elements carry two overlapping genes, TyA and TyB, expressed from a single genomic mRNA (15, 23) . TyA encodes a structural protein that directs the formation of virus like particles. TyB encodes a multiprotein product with protease, reverse transcriptase, and integrase activities. TyB is initially expressed as TyA-TyB polyprotein by ribosome frameshifting (15, 23) . This protein along with the mRNA is incorporated into VLPs where the protease activity encoded by the N terminus of TyB liberates TyB reverse transcriptase/RNaseH protein. An in vivo assay was developed by Curcio and Garfinkel (17) for the selection of RNA intermediate-transposition of the Ty1 element, in which a HIS3 gene interrupted by an artificial intron in the antisense orientation was tagged to Ty genome at the 3Ј end. The intron is located in the sense orientation to Ty1 RNA. Splicing and retrotransposition of marked Ty1 transcripts leads to expression of histidine marker, which is scored as his ϩ colonies on solid medium lacking histidine amino acid. Re-
Expression of HBV Polymerase in Ty1-his3AI Retroelement
cently, this strategy was employed to express HIV RT activity (18, 19) . In the present study, we have utilized a similar strategy to express HBV reverse transcriptase activity. The coding region of HBV pol was cloned in frame with the TyA protein immediately 3Ј to the protease and integrase domain to produce the plasmid pTy1/HBVRT (Fig. 1A) . Two additional constructs, Ty1/HBV⌬RT and Ty1/HBV⌬RH, were developed to serve as negative controls, in which RT or RH domains were deleted, respectively (Fig. 1B) . All constructs were regulated by Gal1 promoter. To reduce RT activity attributable to expression of endogenous Ty1 and Ty2 elements, a spt3 mutant host strain was used. Upon galactose induction, yeast carrying these Ty1 plasmids produce and accumulate large amounts of VLPs (15) . By using this assay, we estimated the Ty1/HBVRT transposition rate between 1 ϫ 10 Ϫ4 and 1.5 ϫ 10 Ϫ4 transpositions per Ty1/HBVRT hybrid element per generation (Table  I) . Variations in the transposition rate of individual hybrid Ty1/HBVRT elements may be due to the relative abundance of their transcripts. Table I summarizes the production of His prototroph colonies by different constructs at 20 and 30°C, respectively. It is important to note that the His3 reporter gene was active only if marked Ty1/HBVRT RNA was spliced prior to reverse transcription carried out by HBV pol protein.
To demonstrate the presence of HBV pol, VLPs purified from both spt Ϫ and spt ϩ yeast strains were examined by immunoblotting. The presence of TyA protein was readily detectable by Coomassie Blue staining and by immunoblotting using TyA antibodies (data not shown). The separated proteins were then transferred onto nitrocellulose and probed with a polyclonal antiserum directed against human HBV pol. An expected ϳ96-kDa (also includes amino acid residues derived from TyB protein and HIV integrase domain) mature HBV pol protein was detected only after induction of spt Ϫ (Fig. 2A, quent analysis, we used an equal amount of precipitated protein fraction in 5% sucrose/B/EDTA, which was previously collected from the interphase of 30%/70% stepwise sucrose gradient. HBV pol antibodies also showed weak cross-reactivity to HIV RT (Fig. 2B, lane 3) . Although the same amounts (10 g) of VLPs were analyzed for immnoblotting, the expression of HBV pol in spt ϩ strain appears to be much higher (Fig. 2,  compare lane 4 of A with lane 6 of B) . This suggests that encapsidation of HBV pol in the VLPs within spt ϩ yeast strain may be facilitated by endogenous Ty reverse transcriptases. Collectively these results suggest that HBV pol (reverse transcriptase/RNaseH) is contained within the VLPs isolated from histidine prototrophs. In this system, as mentioned earlier, the production of His ϩ colonies entirely relies on the reverse transcription function provided by HBV pol protein.
Hybrid Ty1/HBVRT Retroelements Express the Bona Fide HBV RT Activity-A highly unusual behavior of HBV pol is its ability to prime the DNA synthesis. In doing so the first nucleotide (dGTP) is covalently linked to the tyrosine 63 residue. This causes the attached (Ϫ) DNA to partition into the phenol phase. In the present analysis, the HBV pol protein becomes radiolabeled by the transfer of the first [
32 P]dGTP. VLPs were incubated in the RT buffer containing only the ␣-32 P-labeled dGTP in the reaction. The HBV pol trans-labeled product of this reaction was separated by 8% SDS-PAGE (Fig. 3A) . A radiolabeled HBV pol protein band of expected molecular mass was observed (Fig. 3A, lane 1) . No 32 P-dGTP-labeled proteins were observed in uninduced (Fig. 3A, lane 2) or induced yeast cells expressing Ty1/HIVRT (lane 3). HIV RT like other retroviruses utilizes a tRNA molecule for priming minus strand synthesis (9) . A weak priming activity could be seen when [␣-32 P]dCTP was included in the HBV pol reaction (data not shown). These results clearly support the conclusion that the HBV pol protein in the VLPs is functional and is able to initiate priming reaction with dGTP.
Next, we examined an RNA-dependent DNA synthesis initiated by the HBV pol protein within the VLPs. This was accomplished by incubating the VLPs in RT buffer in the presence of dNTPs including ␣-32 P-labeled dCTP without supplying an exogenous primer/template. The resulting nucleic acid covalently linked to the pol protein products were boiled in Laemmli sample buffer and examined by 8% SDS-PAGE (Fig.  3B) . A radiolabeled protein band containing the extended minus DNA strands was observed only in the galactose-induced yeast cells (Fig. 3B, lane 7) , whereas deletion mutants lacking either the RT or RNaseH domains was unable to produce this pattern (Fig. 3B, lanes 4 and 5) . Similarly, HIV RT (Fig. 3B,  lane 3) and Ty1-his3AI (lane 2) failed to produce any radiolabeled bands. This experiment further confirms that newly synthesized labeled DNA is covalently linked to HBV pol, a unique characteristic of hepandaviruses polymerases.
To monitor the extent of DNA synthesis, partially purified VLPs fractions were incubated with dNTPs containing ␣-32 Plabeled dCTP. Reactions were terminated by incubating with proteinase K for 90 min. Proteins were removed by phenolchloroform extraction, and labeled DNA products were resolved by either 4% urea-polyacrylamide or 1.5% alkaline-agarose gel electrophoresis. Where indicated RNase (10 units), actinomycin D (100 M), and micrococcal nuclease (0.1 g/ul) were used prior to DNA synthesis. A series of controls were included in this analysis to establish the bona fide HBV pol activity. The RT products analyzed by 4% urea-PAGE gel electrophoresis are shown in Fig dramatic reduction was seen (lane 4), which is consistent with its previously observed inhibitory activities against viral polymerases and reverse transcriptases (6, 13) . Most importantly, these DNA products disappeared from the aqueous phase during phenol extraction if proteinase K digestion was omitted (compare lanes 2-7 and 10). Acetone precipitation was performed to recover the DNA from phenol phase (lane 13). No RT products were observed in the absence of Mg 2ϩ or when VLPs were treated with RNase prior to RT reaction (Fig. 4A, lanes 8  and 9) . In the reaction with RNase treatment, Mg 2ϩ was included. These data suggest that an authentic reverse transcription reaction has occurred within the purified VLPs. Absence of a band in the mung bean nuclease treated reaction indicates that the RT product is a single-stranded DNA (lane 11). The addition of dideoxy-NTPs did not completely obliterate the RT activity (lane 12). This is consistent with the observation of others that a pool of sufficient amount of nucleotides is present in the VLPs to initiate the RT reaction (6). 3TC is a known inhibitor of reverse transcriptase activities of HIV and HBV. Here, we have used 3TC triphosphate (10 M) to examine its influence on HBV pol activity. As shown in lane 14, 3TC inhibited this reaction. Collectively, these results show that the RT activity is authentically initiated by the HBV polymerase in accordance with the known characteristics of this protein. Further, this also rules out the concerns that endogenous yeast RT activity may have co-purified with the VLPs.
To precisely determine the size of the DNA fragments in the RT reactions within the VLPs purified from pTy1/HBVRTexpressing HIS ϩ yeast cells, the reaction mixtures were analyzed by alkaline-agarose gel electrophoresis (Fig. 4B) . Shown in Fig. 4B (lanes 5 and 8) are the various sizes of DNA bands. There are two discrete DNA fragments of approximately of ϳ5000 and 2000 nucleotides and a diffuse pattern of DNA products ranging from 200 to 800 nucleotides. These DNA bands were absent in uninduced yeast cells and those transformed with HBV RT and RNase H deletion mutants or with Ty1/Gem74 vector (lanes 1-4) . No DNA synthesis was observed when VLPs were treated with RNase prior to RT reaction (lane 6). However, when RNase was added after the RT reaction, RT product was not degraded, suggesting that the DNA synthesis has occurred (lane 8). As was seen before (Fig. 4A, lane 4) , the DNA synthesis was sensitive to actinomycin D at a concentration of 100 g (lane 7). For comparison, we also carried out the RT analysis within the purified VLPs from an spt ϩ yeast strain JSS 56 11-B (Fig. 4C) . These results are consistent with those shown in Fig. 4B . In all lanes, bona fide RT products of ϳ5500 and ϳ600 nucleotides were seen; however, the 2000-nucleotide band was not as pronounced in spt ϩ strain (Fig. 4B) . In this analysis several minor species ranging from 0.8 to 3.5 kilobases were also seen (lanes 1, 3, and 6-8) . Similarly, when no proteinase K was added to the mixture, no RT products were seen (lane 4). The RT products covalently bound with the HBVRT were separated in the interphase. These products were recovered from the interhpase by chilled acetone precipitation, treated with proteinase K, and separated (lane 8). These result firmly establish that the VLPs purified under the his selection, from both spt ϩ and spt Ϫ yeast strains contain the functional HBV RT activity. HBV Reverse Transcription Is Inhibited by 3TC-One of the promising features of the genetic selection of Ty1/HBVRT expression strategy is the ability to screen for inhibitors of RT activity. Recently, Nissley et al. (19) were able to show the inhibitory activity of several compounds by the absence of Ty/HIVRT-expressing yeast growth on solid medium. We have used this method to show HBV RT inhibitory activity of 3TC triphosphate on solid medium. First, the toxicity of 3TC in yeast was determined by growing yeast in the presence or absence of 100 M 3TC, which appeared to be the same. Yeast cells were grown in YMIN with 2% galactose and plated onto solid medium lacking histidine but containing 100 M 3TC-triphosphate to select for HBV RT-mediated events (Fig. 5) . Both during induction in liquid culture (growth on galactose) and selection on solid agar plates (growth in the absence of histidine), inhibitor was present. Although the plate without 3TC showed normal growth (Fig. 5, right) , no viable colonies were seen on the 3TC-containing plate (Fig. 5, left) . The residual growth resembling tiny colonies shown in Fig. 5 (left) was evaluated for further growth. When plated in complete medium no growth was observed. This result establishes the feasibility of this strategy for the detection of compounds with inhibitory activities against the HBV pol activity.
HBV Reverse Transcription Activity Is Stimulated by HBx Protein-Next, we asked whether HBV RT activity is influenced by the viral encoded protein HBx. The rationale of this experiment stems from our recent preliminary experiments, which demonstrate that HBx may be encapsidated within the HBV virions.
2 Additionally, we have also previously shown that HBx protein interacts with single-stranded nucleic acids in a manner that is not sequence-specific (25) . In light of these properties of HBx, we reasoned that HBx protein may influence the HBV RT reaction. To test this hypothesis, bacterially purified histidine-tagged HBx protein was added into the VLPs, during in vitro RT reaction (Fig. 6, lanes 5 and 6) . As a control bovine serum albumin and bacterial lysates were included in the RT reaction mixture (lanes 3 and 4, respectively) . The results of this experiment show that HBx displays stimulatory activity in the RT reaction by at least 3-5-fold. This stimulatory activity was inhibited when anti-HBx serum was included along with HBx in the reaction mixture (lane 7). VLPs are believed to constitute a loose structural conformation that is permeable to a large variety of reagents including small proteins.
DISCUSSION
Although the HBV genome is a DNA molecule, the viral replication occurs via an RNA intermediate (13) . A pregenomic RNA is packaged in immature core particles, wherein it is reverse transcribed by the HBV-encoded polymerase. Reverse transcription occurs within the core particles (13) (14) (15) (16) . Despite several attempts to express the pol gene, the biochemical dissection of the protein has lagged behind because of the unavailability of soluble enzyme in amounts required for such an analysis. In this communication we have employed a novel hybrid yeast-based Ty retrotransposon to express the HBV pol protein. The strategy was first developed by Curcio and Garfinkel (17) and subsequently utilized to express HIV reverse transcriptase activity (18, 19) that is genetically marked for the event of reverse transcription and genomic transposition. The Ty/HIVRThis3A1 expression system includes a histidine marker that is scored following DNA integration and thus offers a simple genetic selection for the expression of RT or RNaseH activities. Using this strategy, nucleoside and nonnucleoside inhibitors of HIV RT enzyme were identified (19) , thus establishing the feasibility of the system for large scale screening. In using this system, the results of our experiments show that HBV pol activity was fully functional. The biochemical data presented in this report clearly demonstrate that HBV pol was able to produce minus strands of DNA and that this activity was protein-primed, consistent with the characteristic feature of this enzyme. We have further used the system to demonstrate the inhibitory activity of a known compound 3TC by the failure of Ty1/HBVRT-expressing yeast to grow on solid medium containing the drug. Thus this preliminary report demonstrates the expression of HBV pol in yeast and provides the potential for large scale screening of anti-viral drugs against HBV replication and infection. Additionally, the yeast Ty1/HB-VRT hybrid system might prove suitable for large scale production of the enzyme for detailed evaluation of biochemical properties of HBV pol function, an opportunity thus far unavailable.
The minus strand synthesis has been shown to initiate within the ⑀ bulge located in the 5Ј end of pregenome RNA (2, 20 -22) . Because ⑀ sequences were not included in the construction of Ty1/HBVRT hybrid vector, the reverse transcription must have initiated at some site resembling an ⑀ secondary structure or at a random site in the Ty1/HBVRT RNA. The fact that VLPs were purified from histidine prototrophs suggests that sufficient amounts of HBV pol were made to produce a suitable HIS cDNA substrate for integration into the yeast chromosome, the subsequent expression of which leads to histidine prototrophy. Identification of site(s) of initiation of DNA synthesis is currently being characterized. HBV polymerase has been shown to initiate DNA synthesis in the absence of native ⑀ motif (6) . The distinguishing feature of the work reported here is that transposition of Ty DNA can occur only if HIS marker and or the entire Ty RNA is reverse transcribed and faithfully transposed to a given chromosomal locus and expressed. Furthermore, HBV RT and RH inhibitors can be quantitatively assayed in the present system. We have not examined the length of the transposed DNA in His ϩ yeast, but these characterizations are currently underway. This assay system may also provide an invaluable tool for the identification of viral and cellular cofactors required for enhancement of HBV replication. Using this expression system, we show that HBx protein stimulates the RT reaction within VLPs (Fig. 6) . Although the importance of this observation is presently not clear, such a property has been previously noted for HIV TAT, which stimulates the HIV RT activity (24) .
Finally, the system provides a potential for investigating naturally occurring drug-resistant mutants of HBV pol. There are an estimated 500 million carriers of HBV worldwide who pose a threat of transmitting the disease. Although the HBV vaccine has been available and the cases of HBV infections have shown dramatic reduction in high risk areas, the ability to interfere an ongoing infection still remains a major world health problem. Anti-viral drugs with inhibitory activity against the HBV offer an unique opportunity to arrest the persistent infection of HBV in those individuals. The approach described is safe and economical, requires no biohazard, and is particularly useful for large scale screening of novel inhibitors of HBV reverse transcriptase activity.
